Newsroom
TUUS gets CHF 150,000 from Venture Kick to bring steady-release nutrition and drug delivery to market
27.05.2026
The foodtech startup TUUS has obtained CHF 150,000 from Venture Kick to advance a plant-based hydrogel platform for the controlled ... more
201 Therapeutics receives CHF 40,000 from Venture Kick to advance liver cancer therapy commercialization
26.05.2026
201 Therapeutics receives CHF 40,000 from Venture Kick to advance its oral small-molecule therapies for hepatocellular carcinoma. ... more
Biodelphis Therapeutics receives CHF 150,000 from Venture Kick to advance targeted therapies for difficult-to-treat cancers
22.05.2026
The EPFL spin-off Biodelphis Therapeutics has obtained CHF 150,000 from Venture Kick to develop a new generation of targeted thera ... more
Newsletter Archive
Spring momentum across Swiss startups 🌱
A record 2025, and kicking bigger in 2026! 🚀
Kicking Finish, Bold Outlook✨
Press releases
Press review
1000 Unternehmen mit Venture Kick gegründet
Media contacts
For media enquiries, please email our communications team. If you have a general question about Venture Kick please visit our about us page.
Learn more about Venture Kick or download the latest annual report for detailed information.
